Home>Topics>Companies>Novo Nordisk

Novo Nordisk

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. European shares post 2015's biggest weekly fall despite Novo Nordisk surge

    Headlines

    Fri, 27 Mar 2015

    * FTSEurofirst 300 up 0.2 pct after losing 1.9 pct in two days

  2. European shares set for 2015's biggest weekly fall despite Novo Nordisk surge

    Headlines

    Fri, 27 Mar 2015

    * Euro zone shares recover as euro falls back (Recasts, adds quotes)

  3. Novo Nordisk surge buoys European shares after two-day slide

    Headlines

    Fri, 27 Mar 2015

    * Euro zone shares recover as euro falls back (Adds quote, detail, updates prices)

  4. Europe shares snap two-day slide; Novo Nordisk rallies

    Headlines

    Fri, 27 Mar 2015

    PARIS, March 27 (Reuters) - European stocks rose in early trade on Friday, halting a sharp two-day retreat as a renewed fall in the euro helped boost exporters' shares.

  5. UPDATE 2- Novo Nordisk surges on plan to resubmit rejected insulin in U.S.

    Headlines

    Fri, 27 Mar 2015

    * Shares in Danish group hit all-time high (Updates with shares, analyst reaction)

  6. European shares snap two-day slide; Novo Nordisk rallies

    Headlines

    Fri, 27 Mar 2015

    PARIS, March 27 (Reuters) - European stocks rose in early trade on Friday, halting a sharp two-day retreat as a renewed fall in the euro currency helped boost the shares of exporting companies.

  7. UPDATE 1 - Novo Nordisk filing move brings Tresiba closer to U.S. market

    Headlines

    Thu, 26 Mar 2015

    March 26 (Reuters) - Denmark's Novo Nordisk said on Thursday it had decided to submit interim analysis data from a clinical trial of its crucial new insulin drug Tresiba to U.S. regulators within the next month.

  8. Novo Nordisk to submit interim data on Tresiba drug in U.S.

    Headlines

    Thu, 26 Mar 2015

    March 26 (Reuters) - Denmark's Novo Nordisk said on Thursday it had decided to submit interim analysis data from a clinical trial of its crucial new insulin drug Tresiba to U.S. regulators within the next month.

  9. BRIEF- Novo Nordisk to resubmit U.S. new drug applications for Tresiba and Ryzodeg

    Headlines

    Thu, 26 Mar 2015

    * Has decided to resubmit the new drug applications of Tresiba and Ryzodeg in the U.S.Source text for Eikon: Further company coverage: (Reporting By Ben Hirschler)

  10. Novo Nordisk's FDA Resubmission for Tresiba on Track; Maintaining Our FV and Sales Estimates

    Commentary

    Thu, 26 Mar 2015

    Novo Nordisk has decided to resubmit its applications ..... trials. We had already anticipated that Novo would file in 2015 based on an interim analysis ..... think this decision supports our thesis that Novo possesses strong intangible assets in the

« Prev12345Next »
Content Partners